000 | 01900 a2200601 4500 | ||
---|---|---|---|
005 | 20250517233033.0 | ||
264 | 0 | _c20191007 | |
008 | 201910s 0 0 eng d | ||
022 | _a1538-7445 | ||
024 | 7 |
_a10.1158/0008-5472.CAN-18-1327 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBarnoud, Thibaut | |
245 | 0 | 0 |
_aTailoring Chemotherapy for the African-Centric S47 Variant of TP53. _h[electronic resource] |
260 |
_bCancer research _c10 2018 |
||
300 |
_a5694-5705 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAfrica |
650 | 0 | 4 |
_aBlack or African American _xgenetics |
650 | 0 | 4 | _aAlleles |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aBlack People _xgenetics |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCell Transformation, Neoplastic |
650 | 0 | 4 |
_aCisplatin _xpharmacology |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aFibroblasts _xmetabolism |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMitochondria _xmetabolism |
650 | 0 | 4 |
_aMutation _xdrug effects |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 | _aPrecision Medicine |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
700 | 1 | _aBudina-Kolomets, Anna | |
700 | 1 | _aBasu, Subhasree | |
700 | 1 | _aLeu, Julia I-Ju | |
700 | 1 | _aGood, Madeline | |
700 | 1 | _aKung, Che-Pei | |
700 | 1 | _aLiu, Jingjing | |
700 | 1 | _aLiu, Qin | |
700 | 1 | _aVillanueva, Jessie | |
700 | 1 | _aZhang, Rugang | |
700 | 1 | _aGeorge, Donna L | |
700 | 1 | _aMurphy, Maureen E | |
773 | 0 |
_tCancer research _gvol. 78 _gno. 19 _gp. 5694-5705 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-18-1327 _zAvailable from publisher's website |
999 |
_c28737760 _d28737760 |